SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029687
Filing Date
2018-11-15
Accepted
2018-11-15 16:43:44
Documents
48
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eq-10q_20180930.htm 10-Q 1364225
2 EX-31.1 eq-ex311_46.htm EX-31.1 14279
3 EX-31.2 eq-ex312_45.htm EX-31.2 14368
4 EX-32.1 eq-ex321_47.htm EX-32.1 7514
  Complete submission text file 0001564590-18-029687.txt   3847499

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT eq-20180930.xml EX-101.INS 561187
6 XBRL TAXONOMY EXTENSION SCHEMA eq-20180930.xsd EX-101.SCH 31574
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eq-20180930_cal.xml EX-101.CAL 29714
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eq-20180930_def.xml EX-101.DEF 124259
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20180930_lab.xml EX-101.LAB 252146
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20180930_pre.xml EX-101.PRE 217626
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 108 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 108 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 181187711
SIC: 2834 Pharmaceutical Preparations